Boston, MA —— Boston-based company Predictive Healthcare, in a collaboration with Mass General Brigham (MGB), one of the world’s leading integrated healthcare systems, is piloting a cutting-edge digital health platform that could redefine how surgeons prevent post-surgical complications. Dr. Theofanie Mela, MD, Staff Cardiac Electrophysiologist and Director of the Lead Management Program at Massachusetts General Hospital, is spearheading a clinical study using MyHealthPal, an AI-powered wound monitoring app developed by Predictive Healthcare.

Surgical site infections (SSIs) remain among the most dangerous and costly complications in surgery, occurring in up to four percent of procedures and driving preventable hospital readmissions. For patients with cardiovascular implantable electronic devices, (CIEDs), the stakes are even higher: one in five patients with a CIED infection die within one year.

How It Works:
Using the MyHealthPal app, patients capture high-quality images of their surgical incision and answer surgeon-selected wound health questions. Predictive Healthcare’s proprietary AI analyzes the inputs in real time, flagging elevated infection risk before symptoms escalate. Surgeons receive secure alerts through a provider dashboard, enabling earlier interventions, reduced complications, and stronger patient-clinician connections.

“Remote monitoring to support postoperative patient safety and early detection of complications is important. For CIED patients, where infection can be devastating, earlier detection could be lifesaving,” said Dr. Mela.

Early Traction:
The pilot has already enrolled 50 patients, and is showing promising early outcomes. Predictive Healthcare is also expanding trials to additional specialties, including plastic and reconstructive surgery at Tufts Medical Center, with plans for multi-center adoption across leading hospital systems.

Beyond Wound Care:
Built for seamless integration into EHR workflows, MyHealthPal also supports pre- and post-operative care through patient education, wellness tracking, and AI-driven triage tools, offering hospitals a scalable solution to improve outcomes and reduce costly readmissions.

“This collaboration with MGB underscores our mission: harnessing AI to reimagine surgical recovery,” said Talal Ali Ahmad, CEO and founder of Predictive Healthcare.

“By giving clinicians earlier insights and patients greater peace of mind, we’re closing a critical gap in surgical care.”

What’s Next:
The study will continue through 2025, with results to be published on infection prediction accuracy, patient compliance, and readmission reduction. Predictive Healthcare is actively engaging additional hospital systems, surgical innovators, and strategic investors to accelerate commercialization.

Surgeons, hospital leaders, and investors interested in piloting or partnering are invited to connect with CEO Talal Ali Ahmad at [email protected].

About Predictive Healthcare
Predictive Healthcare is a Boston-based health technology company making surgical recovery safer, smarter, and more connected. Its patented, FDA-listed, HIPAA-compliant product, MyHealthPal, leverages AI-enabled patient triage and remote monitoring to help clinicians detect surgical site infections earlier, reduce readmissions, and improve quality of care.